CAR-T 细胞治疗在新型抗原靶点中前 30 天的感染并发症
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days.
46.9分
★★★☆☆
站内排序·非疗效
FRONTIER PAPERS
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days.
Quantitative pharmacology of dual-targeted bicistronic CAR-T-cell therapy using multiscale mechanistic modeling.
The Glass Wall: Gendered Authorship Disparities in CD 19 and BCMA CAR-T Clinical Trials for Lymphoma and Myeloma.
我们的数据提示,在免疫效应细胞治疗领域存在针对女性研究者的性别不平等。
共 3 条
MEMBER ACCOUNT
登录成功会直接打开下一页。